Literature DB >> 22210288

Seroprevalence of bovine leukemia virus (BLV) infection in dairy cattle in Isfahan Province, Iran.

Hassan Morovati1, Edris Shirvani, Vahid Noaman, Mohsen Lotfi, Morteza Kamalzadeh, Alireza Hatami, Masoume Bahreyari, Zahra Shahramyar, Mohammad H Morovati, Mahmoud Azimi, Davoud Sakhaei.   

Abstract

Bovine leukemia virus (BLV), the causative agent of enzootic bovine leukosis (EBL) is an exogenous C-type oncovirus in the Retroviridae family. It causes significant economic losses associated with the costs of control and eradication programs due to carcass condemnation at slaughter and restrictions of export of cattle and semen to importing countries. The main objective of this research was to determine the seroprevalence of BLV infection in cattle herds in central region of Iran (Isfahan province) using a commercial enzyme-linked immunosorbent assay (ELISA) to detect serum antibodies against BLV. Samples of blood serum were collected from 403 female dairy cattle (Holstein-Friesian) from 21 livestock farms and 303 animals (81.9%) were BLV seropositive. A significant association was found between age as a potential risk factor and BVL seroprevalence with animals ≥ 4 years (86.6%) having a significantly (χ(2) = 35.6, p < 0.001) higher seroprevalence compared to those < 4 years (54.2%). We found no significant statistical association between seroprevalence and pregnancy, lactation status and farming systems as potential risk factors in this study (p > 0.1). It is concluded that BLV infection is a very common problem in the study area. Hence, control measures should be instituted to combat the disease and further studies are required to investigate the impact of this disease on dairy production in the country.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22210288     DOI: 10.1007/s11250-011-0062-4

Source DB:  PubMed          Journal:  Trop Anim Health Prod        ISSN: 0049-4747            Impact factor:   1.559


  1 in total

Review 1.  Preventive and therapeutic strategies for bovine leukemia virus: lessons for HTLV.

Authors:  Sabrina M Rodríguez; Arnaud Florins; Nicolas Gillet; Alix de Brogniez; María Teresa Sánchez-Alcaraz; Mathieu Boxus; Fanny Boulanger; Gerónimo Gutiérrez; Karina Trono; Irene Alvarez; Lucas Vagnoni; Luc Willems
Journal:  Viruses       Date:  2011-07-19       Impact factor: 5.048

  1 in total
  4 in total

1.  Molecular characterization of bovine leukemia virus from Moldovan dairy cattle.

Authors:  Aneta Pluta; Marzena Rola-Łuszczak; Piotr Kubiś; Svetlana Balov; Roman Moskalik; Bhudipa Choudhury; Jacek Kuźmak
Journal:  Arch Virol       Date:  2017-02-17       Impact factor: 2.574

2.  In vitro and in vivo antivirus activity of an anti-programmed death-ligand 1 (PD-L1) rat-bovine chimeric antibody against bovine leukemia virus infection.

Authors:  Asami Nishimori; Satoru Konnai; Tomohiro Okagawa; Naoya Maekawa; Ryoyo Ikebuchi; Shinya Goto; Yamato Sajiki; Yasuhiko Suzuki; Junko Kohara; Satoshi Ogasawara; Yukinari Kato; Shiro Murata; Kazuhiko Ohashi
Journal:  PLoS One       Date:  2017-04-26       Impact factor: 3.240

3.  Molecular Characterization of Bovine Leukemia Virus with the Evidence of a New Genotype Circulating in Cattle from Kazakhstan.

Authors:  Akhmetzhan Sultanov; Marzena Rola-Łuszczak; Saltanat Mamanova; Anna Ryło; Zbigniew Osiński; Meruyert A Saduakassova; Elvira Bashenova; Jacek Kuźmak
Journal:  Pathogens       Date:  2022-01-28

4.  First Report of Bovine Leukemia Virus Infection in Yaks (Bos mutus) in China.

Authors:  Jian-Gang Ma; Wen-Bin Zheng; Dong-Hui Zhou; Si-Yuan Qin; Ming-Yang Yin; Xing-Quan Zhu; Gui-Xue Hu
Journal:  Biomed Res Int       Date:  2016-06-02       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.